Hepatocellular adenoma: Difference between revisions
Nawal Muazam (talk | contribs) No edit summary |
Nawal Muazam (talk | contribs) No edit summary |
||
Line 5: | Line 5: | ||
{{CMG}}; {{AOEIC}} [[User:zorkun|Cafer Zorkun, M.D., PhD.]], {{NM}} | {{CMG}}; {{AOEIC}} [[User:zorkun|Cafer Zorkun, M.D., PhD.]], {{NM}} | ||
{{SK}} Hepadenoma; Hepatic adenoma; Liver cell adenoma; Liver adenoma; Liver cell adenomatosis; Hepatocyte adenoma; Inflammatory hepatic adenoma; ''HNF1-alpha'' mutated hepatic adenoma; ''Beta-catenin'' mutated hepatic adenoma | {{SK}} Hepadenoma; Hepatic adenoma; Liver cell adenoma; Liver adenoma; Liver cell adenomatosis; Hepatocyte adenoma; Inflammatory hepatic adenoma; ''HNF1-alpha'' mutated hepatic adenoma; ''Beta-catenin'' mutated hepatic adenoma; Hepatocyte benign tumor | ||
==[[Hepatocellular adenoma overview|Overview]]== | ==[[Hepatocellular adenoma overview|Overview]]== |
Revision as of 13:46, 30 October 2015
For patient information, click here
Hepatocellular adenoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hepatocellular adenoma On the Web |
American Roentgen Ray Society Images of Hepatocellular adenoma |
Risk calculators and risk factors for Hepatocellular adenoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., PhD., Nawal Muazam M.D.[2]
Synonyms and keywords: Hepadenoma; Hepatic adenoma; Liver cell adenoma; Liver adenoma; Liver cell adenomatosis; Hepatocyte adenoma; Inflammatory hepatic adenoma; HNF1-alpha mutated hepatic adenoma; Beta-catenin mutated hepatic adenoma; Hepatocyte benign tumor
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Epidemiology and Demographics
Risk Factors
Screening
Differentiating Hepatocellular adenoma from other Diseases
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies